Cribriform Morular Thyroid Carcinoma - Ultimobranchial Pouch-Related? Deep Molecular Insights of a Unique Case.

Dettmer, Matthias S; Hürlimann, Sandra; Scheuble, Lukas; Vassella, Erik; Perren, Aurel; Wicke, Corinna (2023). Cribriform Morular Thyroid Carcinoma - Ultimobranchial Pouch-Related? Deep Molecular Insights of a Unique Case. Endocrine pathology, 34(3), pp. 342-348. Springer 10.1007/s12022-023-09775-z

[img]
Preview
Text
s12022-023-09775-z.pdf - Published Version
Available under License Creative Commons: Attribution (CC-BY).

Download (1MB) | Preview

A 44-year-old female patient with a familial adenomatous polyposis (FAP) was diagnosed with a cribriform morular thyroid carcinoma (CMTC). We observed within the very necrotic tumor a small but distinct poorly differentiated carcinomatous component. As expected, next generation sequencing of both components revealed a homozygous APC mutation and in addition, a TERT promoter mutation. A TP53 mutation was found exclusively in the CMTC part, while the poorly differentiated component showed a clonal evolution, harboring an activating PIK3CA mutation and copy number gains of BRCA2, FGF23, FGFR1, and PIK3CB-alterations which are typically seen in squamous cell carcinoma. The mutational burden in both components was low, and there was no evidence for microsatellite instability. No mutations involving the mitogen-activated protein kinase (MAPK) pathway, typically seen in papillary thyroid carcinomas, were detected. Immunohistochemically, all tumor parts were negative for thyroglobulin, providing further evidence that this entity does not belong to the follicular epithelial cell-derived thyroid carcinoma group. CD5 was negative in the poorly differentiated component, making a relation to intrathyroidal thymic carcinoma rather unlikely. However, since this marker was seen in the morules, a loss in the poorly differentiated component and a relation to the ultimobranchial body cannot be excluded either. After total thyroidectomy and radioiodine ablation, the patient was disease-free with no residual tumor burden on 2-year follow-up.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Service Sector > Institute of Pathology > Clinical Pathology
04 Faculty of Medicine > Service Sector > Institute of Pathology

UniBE Contributor:

Dettmer, Matthias, Vassella, Erik, Perren, Aurel

Subjects:

500 Science > 570 Life sciences; biology
600 Technology > 610 Medicine & health

ISSN:

1559-0097

Publisher:

Springer

Language:

English

Submitter:

Pubmed Import

Date Deposited:

31 May 2023 09:01

Last Modified:

21 Sep 2023 00:13

Publisher DOI:

10.1007/s12022-023-09775-z

PubMed ID:

37249797

Uncontrolled Keywords:

Clonal evolution Cribriform morular FAP NGS Squamous cell component Thyroid carcinoma

BORIS DOI:

10.48350/183041

URI:

https://boris.unibe.ch/id/eprint/183041

Actions (login required)

Edit item Edit item
Provide Feedback